Resmed Inc. buy KeyCorp
Start price
06.02.24
/
50%
€178.25
Target price
06.02.25
€211.50
Performance (%)
28.64%
End price
07.02.25
€229.30
Summary
This prediction ended on 07.02.25 with a price of €229.30. The BUY prediction by KeyCorp finished with a performance of 28.64%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.87 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 7.264% | 7.264% | -25.525% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten